查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1875954

全球多重免疫检测分析市场

Multiplex Detection Immunoassays
出版日期: | 出版商: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 英文 182 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

预计2030年，全球多重免疫检测市场规模将达35亿美元。

2024年全球多重检测免疫检测市场规模预计为29亿美元，预计到2030年将达35亿美元，在分析期（2024-2030年）内复合年增长率（CAGR）为3.4%。本报告分析的细分市场之一—基于蛋白质的多重检测技术，预计将以3.6%的复合年增长率成长，并在分析期结束时达到24亿美元。基于核酸的多重检测技术细分市场预计在分析期间内将以3.2%的复合年增长率成长。

美国市场规模估计为7.651亿美元，而中国市场预计将以3.3%的复合年增长率成长。

预计2024年，美国多重免疫检测市场规模将达7.651亿美元。作为世界第二大经济体，中国预计到2030年市场规模将达到5.64亿美元，在2024年至2030年的分析期间内，复合年增长率（CAGR）为3.3%。其他值得关注的区域市场包括日本和加拿大，预计在分析期间内，这两个市场的复合年增长率分别为3.2%和2.8%。在欧洲，德国的复合年增长率预计约为3.4%。

全球多重检测免疫检测市场—关键趋势与驱动因素概述

什么是多重免疫检测？它的工作原理是什么？

多重检测免疫检测是一种专门的诊断工具，它利用免疫学检测技术，在单一检体中同时检测多种抗原或抗体。这些检测法利用抗体特异性结合标靶分子，从而实现多种分析物的同步检测和定量，使其在临床诊断和研究中都具有极高的应用价值。多重检测免疫检测广泛应用于免疫学、感染疾病和肿瘤学领域，用于监测免疫反应、检测生物标记和早期疾病诊断。与传统的单分析检测法相比，多重检测免疫分析能够以极少的检体提供高通量、详细的结果，从而显着提高工作流程效率和诊断准确性。

科技进步如何改变多重检测免疫检测？

检测设计、检测方法和微流体技术的进步正在迅速提升多重免疫分析的效能。萤光和化学冷光检测系统的创新显着提高了这些检体的灵敏度和特异性，使得在更低浓度下检测生物标记成为可能。微流体和晶片实验室技术实现了更紧凑、更有效率的多重分析，在提高通量的同时减少了样品和试剂的用量。此外，人工智慧驱动的数据分析和自动化平台等数位技术的整合提高了分析结果解读的速度和准确性。这些进步拓展了多重免疫分析的应用范围，使其在个人化医疗、疫苗研发、照护现场诊断等领域得到更广泛的应用。

精准诊断的需求如何推动多重免疫检测技术的应用？

精准诊断日益受到重视，它能够根据每位患者独特的分子特征提供个人化医疗服务，这推动了多重免疫检测的应用。这些检测法使临床医生能够在一次检测中分析多种疾病标记物，从而更全面地了解患者的健康状况。例如，在感染疾病诊断中，多重检测法可以同时检测多种病原体，提高诊断准确性并加快治疗速度。在肿瘤学领域，它们用于监测癌症治疗的免疫反应并检测肿瘤标记。个人化医疗对高效、精细诊断的需求不断增长，推动了多重检测免疫检测在各种医疗应用领域的广泛应用。

多重免疫检测市场的主要成长要素是什么？

多重检测免疫检测市场成长受多种因素驱动，包括技术进步、对精准诊断日益增长的需求以及对疾病早期检测的日益重视。检测技术和分析方法设计的创新使这些免疫检测更加灵敏且扩充性，从而促进了其在临床诊断和研究中的广泛应用。慢性病和感染疾病（例如癌症和新冠肺炎）的日益流行，推动了对更全面诊断工具的需求，进而促进了多重检测免疫检测的应用。此外，个人化医疗的扩展和生物标记发现日益重要，也促进了对这些检测法的需求，这些方法能够对疾病状态和治疗反应进行详细分析。

部分：

依技术（基于蛋白质的多重检测技术、基于核酸的检测技术、基于生物感测器的检测技术）、按应用（疾病检测、食品污染检测、药物研发、兽医疾病检测）分类

受访公司范例

  • BD Biosciences
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
  • F. Hoffmann-La Roche AG
  • Luminex Corporation
  • Microsynth AG
  • MilliporeSigma
  • Qiagen NV
  • Quansys Biosciences
  • Thermo Fisher Scientific, Inc.
  • Unisensor

人工智慧集成

我们正在利用检验的专家内容和人工智慧工具，改变您分析市场和竞争情报的方式。

Market Glass, Inc. 并没有采用查询LLM 或产业专用的SLM 的典型方法，而是建立了一个由世界各地领域专家精心策划的内容库，其中包括视频转录、博客、搜寻引擎研究以及大量的公司、产品/服务和市场数据。

关税影响係数

在最新发布的报告中，Market Glass, Inc. 将关税对地理市场的影响纳入考量，并根据公司总部所在地、製造地以及进出口（成品和OEM产品）情况，预测企业竞争地位的变化。这种复杂多变的市场现实会从多个方面影响竞争对手，包括增加销货成本、降低盈利和重组供应链，同时也会影响微观和宏观市场动态。

目录

第一章调查方法

第二章执行摘要

  • 市场概览
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章 市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 其他欧洲
  • 亚太地区
  • 世界其他地区

第四章 竞赛

简介目录
Product Code: MCP13508

Global Multiplex Detection Immunoassays Market to Reach US$3.5 Billion by 2030

The global market for Multiplex Detection Immunoassays estimated at US$2.9 Billion in the year 2024, is expected to reach US$3.5 Billion by 2030, growing at a CAGR of 3.4% over the analysis period 2024-2030. Protein-Based Multiplex Technique, one of the segments analyzed in the report, is expected to record a 3.6% CAGR and reach US$2.4 Billion by the end of the analysis period. Growth in the Nucleic Acid Based Technique segment is estimated at 3.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$765.1 Million While China is Forecast to Grow at 3.3% CAGR

The Multiplex Detection Immunoassays market in the U.S. is estimated at US$765.1 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$564.0 Million by the year 2030 trailing a CAGR of 3.3% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.2% and 2.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.4% CAGR.

Global Multiplex Detection Immunoassays Market - Key Trends & Drivers Summarized

What Are Multiplex Detection Immunoassays and How Do They Work?

Multiplex detection immunoassays are specialized diagnostic tools that allow the simultaneous measurement of multiple antigens or antibodies in a single sample using immunological detection methods. These assays utilize antibodies to specifically bind to target molecules, enabling the detection and quantification of multiple analytes simultaneously, making them invaluable in both clinical diagnostics and research. Multiplex detection immunoassays are widely used in immunology, infectious diseases, and oncology to monitor immune responses, detect biomarkers, and diagnose diseases early. Their ability to provide high-throughput, detailed results from minimal samples offers considerable advantages over traditional single-analyte assays, streamlining workflows and enhancing diagnostic accuracy.

How Are Technological Innovations Transforming Multiplex Detection Immunoassays?

Technological advancements in assay design, detection methods, and microfluidics are rapidly enhancing the performance of multiplex detection immunoassays. Innovations in fluorescent and chemiluminescent detection systems have significantly improved the sensitivity and specificity of these assays, enabling the detection of lower levels of biomarkers. Microfluidics and lab-on-a-chip technologies have also allowed for more compact, efficient multiplex assays, reducing sample and reagent volumes while increasing throughput. Furthermore, the integration of digital technologies, such as AI-driven data analysis and automated platforms, is improving the speed and accuracy of interpreting assay results. These advancements are making multiplex detection immunoassays more versatile, expanding their applications in personalized medicine, vaccine development, and point-of-care diagnostics.

How Is the Demand for Precision Diagnostics Boosting the Use of Multiplex Detection Immunoassays?

The growing emphasis on precision diagnostics, which involves tailoring medical treatment to individual patients based on their unique molecular profiles, is driving the adoption of multiplex detection immunoassays. These assays enable clinicians to analyze multiple disease markers in a single test, providing a more comprehensive understanding of a patient’s health status. In infectious disease diagnostics, for example, multiplex assays allow for the simultaneous detection of multiple pathogens, improving diagnostic accuracy and treatment speed. In oncology, these assays are being used to monitor immune responses to cancer therapies and detect tumor markers. The demand for more efficient and detailed diagnostics in personalized medicine is fueling the growth of multiplex detection immunoassays across various healthcare applications.

What Are the Key Growth Drivers in the Multiplex Detection Immunoassays Market?

The growth in the multiplex detection immunoassays market is driven by several factors, including technological advancements, the increasing demand for precision diagnostics, and the growing focus on early disease detection. Innovations in detection technologies and assay design are making these immunoassays more sensitive and scalable, allowing for broader adoption in clinical diagnostics and research. The rising prevalence of chronic and infectious diseases, such as cancer and COVID-19, is pushing the need for more comprehensive diagnostic tools, driving the use of multiplex detection immunoassays. Additionally, the expansion of personalized medicine and the growing importance of biomarker discovery are contributing to the demand for these assays, as they allow for more detailed analysis of disease states and treatment responses.

SCOPE OF STUDY:

The report analyzes the Multiplex Detection Immunoassays market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Technique (Protein-Based Multiplex Technique, Nucleic Acid Based Technique, Biosensor Based Technique); Application (Disease Testing, Food Contamination Testing, Drug Development, Veterinary Disease Testing)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 14 Featured) -

  • BD Biosciences
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
  • F. Hoffmann-La Roche AG
  • Luminex Corporation
  • Microsynth AG
  • MilliporeSigma
  • Qiagen NV
  • Quansys Biosciences
  • Thermo Fisher Scientific, Inc.
  • Unisensor

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Trade Shocks, Uncertainty, and the Structural Rewiring of the Global Economy
    • How Trump's Tariffs Impact the Market? The Big Question on Everyone's Mind
    • Global Economic Update
    • Multiplex Detection Immunoassays - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Demand for High-Throughput Diagnostic Testing Propels Growth in Multiplex Detection Immunoassays
    • Increasing Prevalence of Infectious Diseases Expands Addressable Market for Multiplex Detection Immunoassays
    • Growing Focus on Personalized Medicine Strengthens Business Case for Multiplex Detection Immunoassays in Biomarker Discovery
    • Technological Advancements in Immunoassay Platforms Propel Innovation in Multiplex Detection Systems
    • Surge in Oncology Research Drives Adoption of Multiplex Detection Immunoassays in Cancer Diagnostics
    • Increasing Use of Multiplex Detection Immunoassays in Vaccine Development Expands Opportunities in Pandemic Response
    • Growth in Point-of-Care Diagnostics Drives Demand for Rapid and Portable Multiplex Immunoassay Kits
    • Rising Importance of Immunotherapy Expands Market for Multiplex Detection Immunoassays in Immunology
    • Increasing Focus on Reducing Healthcare Costs Fuels Demand for Cost-Effective Multiplex Testing Solutions
    • Expansion of Companion Diagnostics in Targeted Therapies Drives Market for Multiplex Detection Immunoassays
    • Technological Advancements in Microfluidics and Lab-on-a-Chip Platforms Propel
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Disease Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Disease Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 3: World 15-Year Perspective for Disease Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Food Contamination Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Food Contamination Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 6: World 15-Year Perspective for Food Contamination Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Drug Development by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Drug Development by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 9: World 15-Year Perspective for Drug Development by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Veterinary Disease Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Veterinary Disease Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 12: World 15-Year Perspective for Veterinary Disease Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Protein-Based Multiplex Technique by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Protein-Based Multiplex Technique by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 15: World 15-Year Perspective for Protein-Based Multiplex Technique by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Nucleic Acid Based Technique by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Nucleic Acid Based Technique by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 18: World 15-Year Perspective for Nucleic Acid Based Technique by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Biosensor Based Technique by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Biosensor Based Technique by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 21: World 15-Year Perspective for Biosensor Based Technique by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 22: World Multiplex Detection Immunoassays Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Multiplex Detection Immunoassays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Multiplex Detection Immunoassays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Multiplex Detection Immunoassays by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Multiplex Detection Immunoassays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 26: USA Recent Past, Current & Future Analysis for Multiplex Detection Immunoassays by Application - Disease Testing, Food Contamination Testing, Drug Development and Veterinary Disease Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Multiplex Detection Immunoassays by Application - Disease Testing, Food Contamination Testing, Drug Development and Veterinary Disease Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: USA 15-Year Perspective for Multiplex Detection Immunoassays by Application - Percentage Breakdown of Value Sales for Disease Testing, Food Contamination Testing, Drug Development and Veterinary Disease Testing for the Years 2015, 2025 & 2030
    • TABLE 29: USA Recent Past, Current & Future Analysis for Multiplex Detection Immunoassays by Technique - Protein-Based Multiplex Technique, Nucleic Acid Based Technique and Biosensor Based Technique - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Multiplex Detection Immunoassays by Technique - Protein-Based Multiplex Technique, Nucleic Acid Based Technique and Biosensor Based Technique Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: USA 15-Year Perspective for Multiplex Detection Immunoassays by Technique - Percentage Breakdown of Value Sales for Protein-Based Multiplex Technique, Nucleic Acid Based Technique and Biosensor Based Technique for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Multiplex Detection Immunoassays by Application - Disease Testing, Food Contamination Testing, Drug Development and Veterinary Disease Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Multiplex Detection Immunoassays by Application - Disease Testing, Food Contamination Testing, Drug Development and Veterinary Disease Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: Canada 15-Year Perspective for Multiplex Detection Immunoassays by Application - Percentage Breakdown of Value Sales for Disease Testing, Food Contamination Testing, Drug Development and Veterinary Disease Testing for the Years 2015, 2025 & 2030
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Multiplex Detection Immunoassays by Technique - Protein-Based Multiplex Technique, Nucleic Acid Based Technique and Biosensor Based Technique - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Multiplex Detection Immunoassays by Technique - Protein-Based Multiplex Technique, Nucleic Acid Based Technique and Biosensor Based Technique Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: Canada 15-Year Perspective for Multiplex Detection Immunoassays by Technique - Percentage Breakdown of Value Sales for Protein-Based Multiplex Technique, Nucleic Acid Based Technique and Biosensor Based Technique for the Years 2015, 2025 & 2030
  • JAPAN
    • Multiplex Detection Immunoassays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Multiplex Detection Immunoassays by Application - Disease Testing, Food Contamination Testing, Drug Development and Veterinary Disease Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Multiplex Detection Immunoassays by Application - Disease Testing, Food Contamination Testing, Drug Development and Veterinary Disease Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: Japan 15-Year Perspective for Multiplex Detection Immunoassays by Application - Percentage Breakdown of Value Sales for Disease Testing, Food Contamination Testing, Drug Development and Veterinary Disease Testing for the Years 2015, 2025 & 2030
    • TABLE 41: Japan Recent Past, Current & Future Analysis for Multiplex Detection Immunoassays by Technique - Protein-Based Multiplex Technique, Nucleic Acid Based Technique and Biosensor Based Technique - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Japan Historic Review for Multiplex Detection Immunoassays by Technique - Protein-Based Multiplex Technique, Nucleic Acid Based Technique and Biosensor Based Technique Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: Japan 15-Year Perspective for Multiplex Detection Immunoassays by Technique - Percentage Breakdown of Value Sales for Protein-Based Multiplex Technique, Nucleic Acid Based Technique and Biosensor Based Technique for the Years 2015, 2025 & 2030
  • CHINA
    • Multiplex Detection Immunoassays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 44: China Recent Past, Current & Future Analysis for Multiplex Detection Immunoassays by Application - Disease Testing, Food Contamination Testing, Drug Development and Veterinary Disease Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Multiplex Detection Immunoassays by Application - Disease Testing, Food Contamination Testing, Drug Development and Veterinary Disease Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: China 15-Year Perspective for Multiplex Detection Immunoassays by Application - Percentage Breakdown of Value Sales for Disease Testing, Food Contamination Testing, Drug Development and Veterinary Disease Testing for the Years 2015, 2025 & 2030
    • TABLE 47: China Recent Past, Current & Future Analysis for Multiplex Detection Immunoassays by Technique - Protein-Based Multiplex Technique, Nucleic Acid Based Technique and Biosensor Based Technique - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: China Historic Review for Multiplex Detection Immunoassays by Technique - Protein-Based Multiplex Technique, Nucleic Acid Based Technique and Biosensor Based Technique Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: China 15-Year Perspective for Multiplex Detection Immunoassays by Technique - Percentage Breakdown of Value Sales for Protein-Based Multiplex Technique, Nucleic Acid Based Technique and Biosensor Based Technique for the Years 2015, 2025 & 2030
  • EUROPE
    • Multiplex Detection Immunoassays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Multiplex Detection Immunoassays by Application - Disease Testing, Food Contamination Testing, Drug Development and Veterinary Disease Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Multiplex Detection Immunoassays by Application - Disease Testing, Food Contamination Testing, Drug Development and Veterinary Disease Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: Europe 15-Year Perspective for Multiplex Detection Immunoassays by Application - Percentage Breakdown of Value Sales for Disease Testing, Food Contamination Testing, Drug Development and Veterinary Disease Testing for the Years 2015, 2025 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Multiplex Detection Immunoassays by Technique - Protein-Based Multiplex Technique, Nucleic Acid Based Technique and Biosensor Based Technique - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Multiplex Detection Immunoassays by Technique - Protein-Based Multiplex Technique, Nucleic Acid Based Technique and Biosensor Based Technique Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: Europe 15-Year Perspective for Multiplex Detection Immunoassays by Technique - Percentage Breakdown of Value Sales for Protein-Based Multiplex Technique, Nucleic Acid Based Technique and Biosensor Based Technique for the Years 2015, 2025 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Multiplex Detection Immunoassays by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Multiplex Detection Immunoassays by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: Europe 15-Year Perspective for Multiplex Detection Immunoassays by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2015, 2025 & 2030
  • FRANCE
    • Multiplex Detection Immunoassays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 59: France Recent Past, Current & Future Analysis for Multiplex Detection Immunoassays by Application - Disease Testing, Food Contamination Testing, Drug Development and Veterinary Disease Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Multiplex Detection Immunoassays by Application - Disease Testing, Food Contamination Testing, Drug Development and Veterinary Disease Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: France 15-Year Perspective for Multiplex Detection Immunoassays by Application - Percentage Breakdown of Value Sales for Disease Testing, Food Contamination Testing, Drug Development and Veterinary Disease Testing for the Years 2015, 2025 & 2030
    • TABLE 62: France Recent Past, Current & Future Analysis for Multiplex Detection Immunoassays by Technique - Protein-Based Multiplex Technique, Nucleic Acid Based Technique and Biosensor Based Technique - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: France Historic Review for Multiplex Detection Immunoassays by Technique - Protein-Based Multiplex Technique, Nucleic Acid Based Technique and Biosensor Based Technique Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: France 15-Year Perspective for Multiplex Detection Immunoassays by Technique - Percentage Breakdown of Value Sales for Protein-Based Multiplex Technique, Nucleic Acid Based Technique and Biosensor Based Technique for the Years 2015, 2025 & 2030
  • GERMANY
    • Multiplex Detection Immunoassays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Multiplex Detection Immunoassays by Application - Disease Testing, Food Contamination Testing, Drug Development and Veterinary Disease Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Multiplex Detection Immunoassays by Application - Disease Testing, Food Contamination Testing, Drug Development and Veterinary Disease Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: Germany 15-Year Perspective for Multiplex Detection Immunoassays by Application - Percentage Breakdown of Value Sales for Disease Testing, Food Contamination Testing, Drug Development and Veterinary Disease Testing for the Years 2015, 2025 & 2030
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Multiplex Detection Immunoassays by Technique - Protein-Based Multiplex Technique, Nucleic Acid Based Technique and Biosensor Based Technique - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Germany Historic Review for Multiplex Detection Immunoassays by Technique - Protein-Based Multiplex Technique, Nucleic Acid Based Technique and Biosensor Based Technique Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: Germany 15-Year Perspective for Multiplex Detection Immunoassays by Technique - Percentage Breakdown of Value Sales for Protein-Based Multiplex Technique, Nucleic Acid Based Technique and Biosensor Based Technique for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Multiplex Detection Immunoassays by Application - Disease Testing, Food Contamination Testing, Drug Development and Veterinary Disease Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Multiplex Detection Immunoassays by Application - Disease Testing, Food Contamination Testing, Drug Development and Veterinary Disease Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: Italy 15-Year Perspective for Multiplex Detection Immunoassays by Application - Percentage Breakdown of Value Sales for Disease Testing, Food Contamination Testing, Drug Development and Veterinary Disease Testing for the Years 2015, 2025 & 2030
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Multiplex Detection Immunoassays by Technique - Protein-Based Multiplex Technique, Nucleic Acid Based Technique and Biosensor Based Technique - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Italy Historic Review for Multiplex Detection Immunoassays by Technique - Protein-Based Multiplex Technique, Nucleic Acid Based Technique and Biosensor Based Technique Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: Italy 15-Year Perspective for Multiplex Detection Immunoassays by Technique - Percentage Breakdown of Value Sales for Protein-Based Multiplex Technique, Nucleic Acid Based Technique and Biosensor Based Technique for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Multiplex Detection Immunoassays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 77: UK Recent Past, Current & Future Analysis for Multiplex Detection Immunoassays by Application - Disease Testing, Food Contamination Testing, Drug Development and Veterinary Disease Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Multiplex Detection Immunoassays by Application - Disease Testing, Food Contamination Testing, Drug Development and Veterinary Disease Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: UK 15-Year Perspective for Multiplex Detection Immunoassays by Application - Percentage Breakdown of Value Sales for Disease Testing, Food Contamination Testing, Drug Development and Veterinary Disease Testing for the Years 2015, 2025 & 2030
    • TABLE 80: UK Recent Past, Current & Future Analysis for Multiplex Detection Immunoassays by Technique - Protein-Based Multiplex Technique, Nucleic Acid Based Technique and Biosensor Based Technique - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: UK Historic Review for Multiplex Detection Immunoassays by Technique - Protein-Based Multiplex Technique, Nucleic Acid Based Technique and Biosensor Based Technique Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: UK 15-Year Perspective for Multiplex Detection Immunoassays by Technique - Percentage Breakdown of Value Sales for Protein-Based Multiplex Technique, Nucleic Acid Based Technique and Biosensor Based Technique for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 83: Rest of Europe Recent Past, Current & Future Analysis for Multiplex Detection Immunoassays by Application - Disease Testing, Food Contamination Testing, Drug Development and Veterinary Disease Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Rest of Europe Historic Review for Multiplex Detection Immunoassays by Application - Disease Testing, Food Contamination Testing, Drug Development and Veterinary Disease Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: Rest of Europe 15-Year Perspective for Multiplex Detection Immunoassays by Application - Percentage Breakdown of Value Sales for Disease Testing, Food Contamination Testing, Drug Development and Veterinary Disease Testing for the Years 2015, 2025 & 2030
    • TABLE 86: Rest of Europe Recent Past, Current & Future Analysis for Multiplex Detection Immunoassays by Technique - Protein-Based Multiplex Technique, Nucleic Acid Based Technique and Biosensor Based Technique - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Rest of Europe Historic Review for Multiplex Detection Immunoassays by Technique - Protein-Based Multiplex Technique, Nucleic Acid Based Technique and Biosensor Based Technique Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: Rest of Europe 15-Year Perspective for Multiplex Detection Immunoassays by Technique - Percentage Breakdown of Value Sales for Protein-Based Multiplex Technique, Nucleic Acid Based Technique and Biosensor Based Technique for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Multiplex Detection Immunoassays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 89: Asia-Pacific Recent Past, Current & Future Analysis for Multiplex Detection Immunoassays by Application - Disease Testing, Food Contamination Testing, Drug Development and Veterinary Disease Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Asia-Pacific Historic Review for Multiplex Detection Immunoassays by Application - Disease Testing, Food Contamination Testing, Drug Development and Veterinary Disease Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: Asia-Pacific 15-Year Perspective for Multiplex Detection Immunoassays by Application - Percentage Breakdown of Value Sales for Disease Testing, Food Contamination Testing, Drug Development and Veterinary Disease Testing for the Years 2015, 2025 & 2030
    • TABLE 92: Asia-Pacific Recent Past, Current & Future Analysis for Multiplex Detection Immunoassays by Technique - Protein-Based Multiplex Technique, Nucleic Acid Based Technique and Biosensor Based Technique - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Asia-Pacific Historic Review for Multiplex Detection Immunoassays by Technique - Protein-Based Multiplex Technique, Nucleic Acid Based Technique and Biosensor Based Technique Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: Asia-Pacific 15-Year Perspective for Multiplex Detection Immunoassays by Technique - Percentage Breakdown of Value Sales for Protein-Based Multiplex Technique, Nucleic Acid Based Technique and Biosensor Based Technique for the Years 2015, 2025 & 2030
  • REST OF WORLD
    • TABLE 95: Rest of World Recent Past, Current & Future Analysis for Multiplex Detection Immunoassays by Application - Disease Testing, Food Contamination Testing, Drug Development and Veterinary Disease Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Rest of World Historic Review for Multiplex Detection Immunoassays by Application - Disease Testing, Food Contamination Testing, Drug Development and Veterinary Disease Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: Rest of World 15-Year Perspective for Multiplex Detection Immunoassays by Application - Percentage Breakdown of Value Sales for Disease Testing, Food Contamination Testing, Drug Development and Veterinary Disease Testing for the Years 2015, 2025 & 2030
    • TABLE 98: Rest of World Recent Past, Current & Future Analysis for Multiplex Detection Immunoassays by Technique - Protein-Based Multiplex Technique, Nucleic Acid Based Technique and Biosensor Based Technique - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Rest of World Historic Review for Multiplex Detection Immunoassays by Technique - Protein-Based Multiplex Technique, Nucleic Acid Based Technique and Biosensor Based Technique Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Rest of World 15-Year Perspective for Multiplex Detection Immunoassays by Technique - Percentage Breakdown of Value Sales for Protein-Based Multiplex Technique, Nucleic Acid Based Technique and Biosensor Based Technique for the Years 2015, 2025 & 2030

IV. COMPETITION